Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Mylan
Sort By
Newest First
1 / 2
1 / 2
Donation
Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19
Mylan
PR-M08-20-NI-22
Aug 14, 2020
COVID-19 Treatment
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
Mylan
PR-M05-20-NI-018
May 14, 2020
Leadership
Mylan Board Appoints Robert J. Coury As Executive Chairman
Mylan
PR-M04-20-NI-026
Apr 17, 2020
M&A
Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mylan
PR-M03-20-NI-041
Mar 26, 2020
Legal Settlement
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission
Mylan
PR-M09-19-NI-060
Sep 30, 2019
Legal
Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case
Nice Insight
PR-M08-19-NI-007
Aug 02, 2019
M&A
Mylan and Upjohn, a Division Of Pfizer, to Combine
Pfizer
PR-M07-19-NI-079
Jul 31, 2019
Recall
Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter
Mylan
PR-M03-19-NI-050
Mar 19, 2019
Opioids
Generic Suboxone Sublingual Film Launched
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-004
Mar 05, 2019
FDA Approval
Mylan Announces FDA Approval of Wixela™ Inhub™, First Generic of ADVAIR DISKUS®
Mylan
PR-M02-19-NI-005
Feb 05, 2019
Launch
Launch of Generic Lialda® Delayed-Release Tablets Expands Mylan's Gastroenterology Product Offering
Mylan
PR-M01-19-NI-001
Jan 02, 2019
Gastroenterology
Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid® SoluTab Delayed-Release Orally Disintegrating Tablets
Mylan
PR-M12-18-NI-022
Dec 07, 2018
FDA Inspection
Mylan Statement in Response to FDA Warning Letter Relating to Morgantown Plant
Mylan
PR-M11-18-NI-093
Nov 27, 2018
Biosimilars
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab
Mylan
PR-M10-18-NI-071
Oct 22, 2018
Clinical Data
Theravance Biopharma and Mylan to Present New Data from Studies of YUPELRI™ (revefenacin) at the 2018 CHEST Annual Meeting
Mylan
PR-M10-18-NI-038
Oct 11, 2018
Biosimilar
Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim
Mylan
PR-M09-18-NI-087
Sep 27, 2018
Generics
Mylan Launches Authorized Generic of Ampyra® Tablets
Mylan
PR-M09-18-NI-089
Sep 27, 2018
Generics
Mylan Launches First Generic for Adcirca® Tablets
Mylan
PR-M09-18-NI-021
Sep 10, 2018
Biosimilar
Mylan and Fujifilm Kyowa Kirin Biologics Announce Positive CHMP Opinion for Hulio™, Biosimilar Adalimumab
Mylan
PR-M08-18-NI-001
Aug 01, 2018
Drug Development
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon® Patch
Mylan
PR-M07-18-NI-028
Jul 10, 2018
